Lorena Fraga - Journalist Profile | Connect with top journalists

Beats

Biography

Estagiária de jornalismo na @arkoadvice | Antes no @Poder360 e @correio | | Jornalismo na UnB | ex-@sosimprensa

Content

Total articles 26

• Available on paid plans

  Mulheres ainda têm pouca representação em cargos-chave nos partidos, apontam especialistas e parlamentares

  By Elisa Clavery, Lorena Fraga Verified

  Mar. 08, 2025

• Available on paid plans

  Calorão: sistema de energia elétrica registra nesta sexta quarto recorde de consumo em 2025

  By Lorena Fraga Verified

  Feb. 21, 2025

• Available on paid plans

  Mulheres ainda têm pouca representação em cargos-chave nos partidos, apontam especialistas e parlamentares

  By Elisa Clavery, Lorena Fraga Verified

  Mar. 08, 2025

As seen in

Company Info

G1

G1 Therapeutics, Inc. is a biopharmaceutical company based in Research Triangle Park, North Carolina. Founded in 2008, it focuses on developing small molecule therapies for cancer treatment. The company aims to improve patient outcomes by targeting cellular pathways involved in cancer progression. G1 Therapeutics became a subsidiary of Pharmacosmos A/S in September 2024. The company's flagship product, COSELA (trilaciclib), is an FDA-approved drug that protects bone marrow from chemotherapy damage. It is administered intravenously before chemotherapy to enhance patient safety. G1 Therapeutics also has a pipeline that includes lerociclib, a CDK4/6 inhibitor, and other investigational compounds aimed at cancer treatment. The company collaborates with organizations like GeneCentric Therapeutics and AstraZeneca to advance its research and clinical trials.